Table 4.
Univariable and Multivariable Analysis of All‐Cause Mortality at 2 Years in Patients With Morbid Obesity (n=910)
|
Univariable Analysis HR (95% CI) |
P Value |
Multivariable Analysis HR (95% CI) |
P Value | |
|---|---|---|---|---|
| COPD | 1.44 (1.01–2.07) | 0.047 | ||
| eGFR per 10 mL/min per 1.73m2 decrease | 1.15 (1.06–1.25) | 0.001 | 1.16 (1.07–1.26) | <0.001 |
| Baseline hemoglobin* | 1.32 (1.06–1.64) | 0.013 | ||
| Major vascular complication | 2.01 (1.51–2.68) | <0.001 | ||
| Life‐threatening bleeding or major bleeding | 2.66 (1.69–4.18) | <0.001 | ||
| Nontransfemoral access | 1.70 (1.37–2.10) | <0.001 | 1.82 (1.19–2.79) | 0.006 |
| General anesthesia | 1.40 (0.98–1.98) | 0.062 | ||
| AKI stage II‐III | 3.94 (2.16–7.17) | <0.001 | ||
| Periprocedure stroke | 4.92 (2.30–10.56) | <0.001 |
AKI indicates acute kidney injury; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; and HR, hazard ratio.
*
For every 2‐g decrease.